Under the Trump administration, the government has rescinded research funding, changed vaccine recommendations, and refused to review Moderna’s new mRNA flu vaccine. That could set vaccine research and development back for years.
Staffing shortages are likely to intensify as the Trump administration ends a program that gave 350,000 Haitians the right to live and work in the United States.